Fixed-dose formulation of nifedipine and lidocaine for the treatment of anal fissures: results from a prospective, multicenter, single-arm and post-marketing observational study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20254082Keywords:
Anal fissure, Anorectal pain, Nifedipine, Lidocaine, Fixed dose formulationsAbstract
Background: Anal fissures are a common cause of severe anorectal pain and impaired quality of life, most often affecting individuals aged 15-40 years. Combination therapy with nifedipine and lidocaine has shown promise for symptom relief and healing, yet Indian clinical data remain scarce, highlighting the need for real-world evaluation of this fixed-dose combination (FDC).
Methods: This prospective, multicenter, single-arm, open-label, post-marketing observational study evaluated the effectiveness and safety of FDC of nifedipine and lidocaine in Indian patients with acute or uncomplicated chronic anal fissures. The primary effectiveness endpoint was improvement in pain management. Secondary endpoints evaluated improvement in fissure healing, number of rescue medications required, global effectiveness and tolerability to therapy. Safety was evaluated by monitoring adverse drug reactions (ADRs).
Results: Fifty patients (male: female, 39:11), with a mean (SD) age of 43.5 (16.1) years were enrolled. Pain intensity decreased significantly from a mean (SD) of 6.6 (0.8) at baseline to 3.7 (1.4) and 1.2 (1.5), respectively at week 3 and 6. At Week 6, 93.0% of patients achieved complete re-epithelialization, with no requirement for rescue medication. The treatment was well tolerated with no incident of ADRs.
Conclusions: The study demonstrated statistically significant pain reduction along with improvements in fissure healing over 6 weeks of treatment with the FDC in Indian patients. The complementary actions of nifedipine and lidocaine contributed to both symptomatic relief and sustained healing, with no ADRs reported. These findings support its effectiveness, acceptability, and suitability as a non-surgical treatment option in routine clinical practice.
Metrics
References
Mapel DW, Schum M, Von Worley A. The epidemiology and treatment of anal fissures in a population-based cohort. BMC Gastroenterol. 2014;14:129. DOI: https://doi.org/10.1186/1471-230X-14-129
Nelson RL. Anal fissure (chronic). BMJ Clin Evid. 2014;2014:0407.
Altomare DF, Binda GA, Canuti S, Landolfi V, Trompetto M, Villani RD. The management of patients with primary chronic anal fissure: a position paper. Tech Coloproctol. 2011;15(2):135-41. DOI: https://doi.org/10.1007/s10151-011-0683-7
Cross KLR, Brown SR, Kleijnen J, Bunce J, Paul M, Pilkington S, et al. The Association of Coloproctology of Great Britain and Ireland guideline on the management of anal fissure. Colorectal Dis. 2023;25(12):2423-57. DOI: https://doi.org/10.1111/codi.16762
Lu Y, Kwaan MR, Lin AY. Diagnosis and Treatment of Anal Fissures in 2021. JAMA. 2021;325(7):688. DOI: https://doi.org/10.1001/jama.2020.16705
Abramowitz L, Sobhani I, Benifla JL, Vuagnat A, Daraï E, Mignon M, et al. Anal Fissure and Thrombosed External Hemorrhoids Before and After Delivery. Dis Colon Rectum. 2002;45(5):650-5. DOI: https://doi.org/10.1007/s10350-004-6262-5
Chaudhary R, Dausage CS. Prevalence of Anal Fissure in Patients with Anorectal Disorders: A Single-centre Experience. JCDR. 2019;13(2):PC05-07. DOI: https://doi.org/10.7860/JCDR/2019/38478.12563
Sharma R, Kaur A, Mittal S, Goyal R, Neki NS. Clinical study of perianal disorders and their management: A study of 200 cases. IJMHR. 2017;3(3):2454-9142.
Varadarajan MS, Sony PS, Anandan H. Prevalence and Clinical Presentation of Fissure-in-ANO in A Tertiary Care Centre. Int J Sci Study. 2018;70:12.
Davids JS, Hawkins AT, Bhama AR, Adina EF, Michael JG, Amy LL, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Anal Fissures. Dis Colon Rectum. 2023;66(2):190-9. DOI: https://doi.org/10.1097/DCR.0000000000002664
Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012;2012(2):CD003431. DOI: https://doi.org/10.1002/14651858.CD003431.pub3
Stewart DB, Gaertner W, Glasgow S, Migaly J, Feingold D, Steele SR. Clinical Practice Guideline for the Management of Anal Fissures. Dis Colon Rectum. 2017;60(1):7-14. DOI: https://doi.org/10.1097/DCR.0000000000000735
Bailey HR, Beck DE, Billingham RP, Binderow SR, Gottesman L, Hull TL, et al. A study to determine the nitroglycerin ointment dose and dosing interval that best promote the healing of chronic anal fissures. Dis Colon Rectum. 2002;45(9):1192-9. DOI: https://doi.org/10.1007/s10350-004-6392-9
Bielecki K, Kolodziejczak M. A prospective randomized trial of diltiazem and glyceryltrinitrate ointment in the treatment of chronic anal fissure. Colorectal Disease. 2003;5(3):256-7. DOI: https://doi.org/10.1046/j.1463-1318.2003.00440.x
Jonas M, Neal KR, Abercrombie JF, Scholefield JH. A randomized trial of oral vs. topical diltiazem for chronic anal fissures. Dis Colon Rectum. 2001;44(8):1074-8. DOI: https://doi.org/10.1007/BF02234624
Golfam F, Golfam P, Golfam B, Pahlevani P. Comparison of Topical Nifedipine with Oral Nifedipine for Treatment of Anal Fissure: A Randomized Controlled Trial. Iran Red Crescent Med J. 2014;16(8):e13592. DOI: https://doi.org/10.5812/ircmj.13592
Perrotti P, Dominici P, Grossi E, Cerutti R, Antropoli C. Topical nifedipine with lidocaine ointment versus active control for pain after hemorrhoidectomy: results of a multicentre, prospective, randomized, double-blind study. Can J Surg. 2010;53(1):17-24.
Patel YR, Foronda ML, Pathmarajah. Treatment of anal fissure with nifedipine/lidocaine ointment: 344. Am J Gastroenterol. 2004;99. DOI: https://doi.org/10.14309/00000434-200410001-00341
Merenstein D, Rosenbaum D. Is topical nifedipine effective for chronic anal fissures? J Fam Pract. 2003;52(3):190-2.
Perrotti P, Bove A, Antropoli C, Molino D, Antropoli M, Balzano A, et al. Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. Dis Colon Rectum. 2002;45(11):1468-75. DOI: https://doi.org/10.1007/s10350-004-6452-1
Ligthelm RJ, Borzì V, Gumprecht J, Kawamori R, Wenying Y, Valensi P. Importance of Observational Studies in Clinical Practice. Clin Ther. 2007;29(6 PART 1):1284-92. DOI: https://doi.org/10.1016/j.clinthera.2007.07.004
Sanei B, Mahmoodieh M, Masoudpour H. Comparison of Topical Glyceryl Trinitrate with Diltiazem Ointment for the Treatment of Chronic Anal Fissure: a Randomized Clinical Trial. Acta Chir Belg. 2009;109(6):727-30. DOI: https://doi.org/10.1080/00015458.2009.11680524
Wang C, Ni J, Xiong Y, Chen J, Li B, Xu L. The efficacy of diltiazem, glyceryl trinitrate, nifedipine, minoxidil, and lidocaine for the medical management of anal fissure: a systematic review and network meta-analysis of randomized controlled trials. Int J Surg. 2025;111(4):3020-9. DOI: https://doi.org/10.1097/JS9.0000000000002263
Golfam F, Golfam P, Khalaj A, Sayed Mortaz SS. The effect of topical nifedipine in treatment of chronic anal fissure. Acta Med Iran. 2010;48(5):295-9.
Katsinelos P, Papaziogas B, Koutelidakis I, Paroutoglou G, Dimiropoulos S, Souparis A, et al. Topical 0.5% nifedipine vs. lateral internal sphincterotomy for the treatment of chronic anal fissure: long-term follow-up. Int J Colorectal Dis. 2006;21(2):179-83. DOI: https://doi.org/10.1007/s00384-005-0766-x
Muthukumarassamy R, Robinson SS, Sarath SC, Raveendran R. Treatment of anal fissures using a combination of minoxidil and lignocaine: a randomized, double-blind trial. Indian J Gastroenterol. 2005;24(4):158-60.